Publication

FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice

Paalvast, Y., Zhou, E., Mulder, N. L., Koehorst, M., Boverhof, R., van Dijk, K. W., Rensen, P. C. N., Kuivenhoven, J. A., Kremoser, C., Wang, Y., Kuipers, F., Groen, A. K. & de Boer, J. F., Aug-2018, In : ATHEROSCLEROSIS. 275, p. E10 1 p.

Research output: Contribution to journalMeeting AbstractAcademic

APA

Paalvast, Y., Zhou, E., Mulder, N. L., Koehorst, M., Boverhof, R., van Dijk, K. W., ... de Boer, J. F. (2018). FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice. ATHEROSCLEROSIS, 275, E10. https://doi.org/10.1016/j.atherosclerosis.2018.06.914

Author

Paalvast, Y. ; Zhou, E. ; Mulder, N. L. ; Koehorst, M. ; Boverhof, R. ; van Dijk, K. Willems ; Rensen, P. C. N. ; Kuivenhoven, J. A. ; Kremoser, C. ; Wang, Y. ; Kuipers, F. ; Groen, A. K. ; de Boer, J. F. / FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice. In: ATHEROSCLEROSIS. 2018 ; Vol. 275. pp. E10.

Harvard

Paalvast, Y, Zhou, E, Mulder, NL, Koehorst, M, Boverhof, R, van Dijk, KW, Rensen, PCN, Kuivenhoven, JA, Kremoser, C, Wang, Y, Kuipers, F, Groen, AK & de Boer, JF 2018, 'FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice', ATHEROSCLEROSIS, vol. 275, pp. E10. https://doi.org/10.1016/j.atherosclerosis.2018.06.914

Standard

FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice. / Paalvast, Y.; Zhou, E.; Mulder, N. L.; Koehorst, M.; Boverhof, R.; van Dijk, K. Willems; Rensen, P. C. N.; Kuivenhoven, J. A.; Kremoser, C.; Wang, Y.; Kuipers, F.; Groen, A. K.; de Boer, J. F.

In: ATHEROSCLEROSIS, Vol. 275, 08.2018, p. E10.

Research output: Contribution to journalMeeting AbstractAcademic

Vancouver

Paalvast Y, Zhou E, Mulder NL, Koehorst M, Boverhof R, van Dijk KW et al. FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice. ATHEROSCLEROSIS. 2018 Aug;275:E10. https://doi.org/10.1016/j.atherosclerosis.2018.06.914


BibTeX

@article{9c1a2935f2b8405e82a7fb9057a1f0b8,
title = "FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice",
author = "Y. Paalvast and E. Zhou and Mulder, {N. L.} and M. Koehorst and R. Boverhof and {van Dijk}, {K. Willems} and Rensen, {P. C. N.} and Kuivenhoven, {J. A.} and C. Kremoser and Y. Wang and F. Kuipers and Groen, {A. K.} and {de Boer}, {J. F.}",
year = "2018",
month = "8",
doi = "10.1016/j.atherosclerosis.2018.06.914",
language = "English",
volume = "275",
pages = "E10",
journal = "ATHEROSCLEROSIS",
issn = "0021-9150",
publisher = "ELSEVIER IRELAND LTD",

}

RIS

TY - JOUR

T1 - FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice

AU - Paalvast, Y.

AU - Zhou, E.

AU - Mulder, N. L.

AU - Koehorst, M.

AU - Boverhof, R.

AU - van Dijk, K. Willems

AU - Rensen, P. C. N.

AU - Kuivenhoven, J. A.

AU - Kremoser, C.

AU - Wang, Y.

AU - Kuipers, F.

AU - Groen, A. K.

AU - de Boer, J. F.

PY - 2018/8

Y1 - 2018/8

U2 - 10.1016/j.atherosclerosis.2018.06.914

DO - 10.1016/j.atherosclerosis.2018.06.914

M3 - Meeting Abstract

VL - 275

SP - E10

JO - ATHEROSCLEROSIS

JF - ATHEROSCLEROSIS

SN - 0021-9150

ER -

ID: 65452509